Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. The company offers coagulation testers, hemorheology testers, erythrocyte sedimentation testers, platelet aggregation testers, diagnostic reagents, quality control products. Its products are used in the prevention, screening, diagnosis, and monitoring of thrombophilia, coronary heart disease, venous thromboembolism, and other thrombotic and bleeding disorders. Beijing Succeeder Technology Inc. was founded in 2003 and is based in Beijing, China.
Metrics to compare | 688338 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688338PeersSector | |
|---|---|---|---|---|
P/E Ratio | 32.2x | 31.1x | −0.6x | |
PEG Ratio | 1.10 | −0.86 | 0.00 | |
Price/Book | 1.8x | 2.9x | 2.6x | |
Price / LTM Sales | 11.0x | 6.9x | 3.4x | |
Upside (Analyst Target) | - | 15.0% | 44.8% | |
Fair Value Upside | Unlock | 16.8% | 6.6% | Unlock |